Time Frame |
Up to 5 years post treatment
|
Adverse Event Reporting Description |
[Not Specified]
|
|
Arm/Group Title
|
Arm A: (Enzalutamide)
|
Arm B: (Enzalutamide, Abiraterone, Prednisone)
|
Arm/Group Description |
Patients receive enzalutamide 160 m...
|
Patients receive enzalutamide 160 m...
|
Arm/Group Description |
Patients receive enzalutamide 160 mg PO QD. Treatment will continue until confirmed disease progression or unacceptable toxicity.
|
Patients receive enzalutamide 160 mg PO QD, abiraterone 1000 mg PO QD, and prednisone 5 mg PO BID. Treatment will continue until confirmed disease progression or unacceptable toxicity.
|
|
|
Arm A: (Enzalutamide)
|
Arm B: (Enzalutamide, Abiraterone, Prednisone)
|
|
Affected / at Risk (%) |
|
Affected / at Risk (%) |
|
Total |
372/657 (56.62%)
|
|
339/654 (51.83%)
|
|
|
|
Arm A: (Enzalutamide)
|
Arm B: (Enzalutamide, Abiraterone, Prednisone)
|
|
Affected / at Risk (%) |
# Events
|
Affected / at Risk (%) |
# Events
|
Total |
232/657 (35.31%)
|
|
269/654 (41.13%)
|
|
Blood and lymphatic system disorders |
|
|
Anemia |
11/657 (1.67%)
|
12 |
8/654 (1.22%)
|
10 |
Febrile neutropenia |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Leukocytosis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Cardiac disorders |
|
|
Acute coronary syndrome |
4/657 (0.61%)
|
4 |
1/654 (0.15%)
|
1 |
Aortic valve disease |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Atrial fibrillation |
3/657 (0.46%)
|
3 |
12/654 (1.83%)
|
14 |
Atrial flutter |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Atrioventricular block complete |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Cardiac arrest |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Cardiac disorders - Other, specify |
8/657 (1.22%)
|
8 |
7/654 (1.07%)
|
10 |
Chest pain - cardiac |
7/657 (1.07%)
|
9 |
7/654 (1.07%)
|
10 |
Heart failure |
3/657 (0.46%)
|
4 |
6/654 (0.92%)
|
8 |
Left ventricular systolic dysfunction |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Mitral valve disease |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Myocardial infarction |
7/657 (1.07%)
|
7 |
6/654 (0.92%)
|
6 |
Sinus bradycardia |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Sinus tachycardia |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Supraventricular tachycardia |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Ventricular tachycardia |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Ear and labyrinth disorders |
|
|
Vertigo |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
3 |
Vestibular disorder |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Endocrine disorders |
|
|
Adrenal insufficiency |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Eye disorders |
|
|
Cataract |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Eye disorders - Other, specify |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Optic nerve disorder |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Retinal detachment |
1/657 (0.15%)
|
11 |
1/654 (0.15%)
|
1 |
Retinopathy |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Gastrointestinal disorders |
|
|
Abdominal distension |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Abdominal pain |
7/657 (1.07%)
|
7 |
5/654 (0.76%)
|
7 |
Ascites |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
2 |
Colonic hemorrhage |
1/657 (0.15%)
|
2 |
1/654 (0.15%)
|
1 |
Colonic obstruction |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
3 |
Constipation |
7/657 (1.07%)
|
9 |
1/654 (0.15%)
|
1 |
Diarrhea |
2/657 (0.30%)
|
2 |
5/654 (0.76%)
|
5 |
Duodenal obstruction |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Duodenal ulcer |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Dyspepsia |
4/657 (0.61%)
|
6 |
1/654 (0.15%)
|
1 |
Dysphagia |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Fecal incontinence |
0/657 (0.00%)
|
0 |
3/654 (0.46%)
|
3 |
Gastric hemorrhage |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Gastric ulcer |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Gastritis |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Gastroesophageal reflux disease |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Gastrointestinal disorders - Oth spec |
0/657 (0.00%)
|
0 |
4/654 (0.61%)
|
5 |
Ileus |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Lower gastrointestinal hemorrhage |
3/657 (0.46%)
|
3 |
1/654 (0.15%)
|
1 |
Nausea |
10/657 (1.52%)
|
11 |
10/654 (1.53%)
|
11 |
Pancreatitis |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Rectal hemorrhage |
1/657 (0.15%)
|
1 |
3/654 (0.46%)
|
3 |
Small intestinal obstruction |
4/657 (0.61%)
|
4 |
2/654 (0.31%)
|
4 |
Stomach pain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Upper gastrointestinal hemorrhage |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Visceral arterial ischemia |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Vomiting |
6/657 (0.91%)
|
8 |
7/654 (1.07%)
|
7 |
General disorders |
|
|
Chills |
2/657 (0.30%)
|
2 |
3/654 (0.46%)
|
3 |
Death NOS |
2/657 (0.30%)
|
2 |
5/654 (0.76%)
|
5 |
Edema limbs |
2/657 (0.30%)
|
2 |
2/654 (0.31%)
|
2 |
Fatigue |
24/657 (3.65%)
|
32 |
28/654 (4.28%)
|
34 |
Fever |
3/657 (0.46%)
|
3 |
8/654 (1.22%)
|
8 |
Flu like symptoms |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Gait disturbance |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
2 |
Gen disord and admin site conds-Oth spec |
1/657 (0.15%)
|
1 |
4/654 (0.61%)
|
4 |
Localized edema |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Multi-organ failure |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Non-cardiac chest pain |
3/657 (0.46%)
|
3 |
5/654 (0.76%)
|
6 |
Pain |
3/657 (0.46%)
|
3 |
2/654 (0.31%)
|
2 |
Sudden death NOS |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
2 |
Hepatobiliary disorders |
|
|
Cholecystitis |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Immune system disorders |
|
|
Anaphylaxis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
2 |
Infections and infestations |
|
|
Appendicitis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Bladder infection |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Bone infection |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
3 |
Bronchial infection |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Enterocolitis infectious |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Infections and infestations - Oth spec |
4/657 (0.61%)
|
6 |
7/654 (1.07%)
|
8 |
Joint infection |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Lung infection |
4/657 (0.61%)
|
4 |
11/654 (1.68%)
|
11 |
Sepsis |
6/657 (0.91%)
|
6 |
16/654 (2.45%)
|
23 |
Sinusitis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Skin infection |
0/657 (0.00%)
|
0 |
3/654 (0.46%)
|
3 |
Tooth infection |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Upper respiratory infection |
1/657 (0.15%)
|
6 |
0/654 (0.00%)
|
0 |
Urinary tract infection |
9/657 (1.37%)
|
11 |
26/654 (3.98%)
|
37 |
Wound infection |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Injury, poisoning and procedural complications |
|
|
Ankle fracture |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Aortic injury |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Bruising |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Burn |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Fall |
16/657 (2.44%)
|
18 |
12/654 (1.83%)
|
14 |
Fracture |
5/657 (0.76%)
|
6 |
9/654 (1.38%)
|
10 |
Hip fracture |
6/657 (0.91%)
|
8 |
6/654 (0.92%)
|
7 |
Inj, pois and proced complic - Oth spec |
5/657 (0.76%)
|
6 |
2/654 (0.31%)
|
2 |
Spinal fracture |
2/657 (0.30%)
|
2 |
1/654 (0.15%)
|
1 |
Wrist fracture |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Investigations |
|
|
Alanine aminotransferase increased |
2/657 (0.30%)
|
2 |
19/654 (2.91%)
|
29 |
Alkaline phosphatase increased |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Aspartate aminotransferase increased |
3/657 (0.46%)
|
3 |
14/654 (2.14%)
|
20 |
Blood bilirubin increased |
0/657 (0.00%)
|
0 |
3/654 (0.46%)
|
3 |
CPK increased |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Cardiac troponin I increased |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Creatinine increased |
3/657 (0.46%)
|
3 |
3/654 (0.46%)
|
4 |
Ejection fraction decreased |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
INR increased |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Investigations - Other, specify |
2/657 (0.30%)
|
2 |
3/654 (0.46%)
|
3 |
Lipase increased |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
3 |
Lymphocyte count decreased |
6/657 (0.91%)
|
6 |
3/654 (0.46%)
|
4 |
Neutrophil count decreased |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Platelet count decreased |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Weight gain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
3 |
Weight loss |
5/657 (0.76%)
|
7 |
2/654 (0.31%)
|
2 |
White blood cell decreased |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Metabolism and nutrition disorders |
|
|
Acidosis |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Anorexia |
4/657 (0.61%)
|
5 |
3/654 (0.46%)
|
3 |
Dehydration |
7/657 (1.07%)
|
8 |
12/654 (1.83%)
|
13 |
Hypercalcemia |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Hyperglycemia |
8/657 (1.22%)
|
8 |
5/654 (0.76%)
|
5 |
Hyperkalemia |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Hypoalbuminemia |
4/657 (0.61%)
|
4 |
1/654 (0.15%)
|
2 |
Hypocalcemia |
0/657 (0.00%)
|
0 |
3/654 (0.46%)
|
4 |
Hypoglycemia |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
2 |
Hypokalemia |
2/657 (0.30%)
|
2 |
13/654 (1.99%)
|
14 |
Hypomagnesemia |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Hyponatremia |
7/657 (1.07%)
|
7 |
5/654 (0.76%)
|
6 |
Hypophosphatemia |
1/657 (0.15%)
|
2 |
1/654 (0.15%)
|
1 |
Musculoskeletal and connective tissue disorders |
|
|
Arthralgia |
2/657 (0.30%)
|
3 |
1/654 (0.15%)
|
1 |
Back pain |
10/657 (1.52%)
|
10 |
6/654 (0.92%)
|
13 |
Bone pain |
13/657 (1.98%)
|
15 |
8/654 (1.22%)
|
10 |
Buttock pain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Flank pain |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Generalized muscle weakness |
7/657 (1.07%)
|
8 |
18/654 (2.75%)
|
22 |
Muscle weakness lower limb |
2/657 (0.30%)
|
2 |
9/654 (1.38%)
|
12 |
Musculoskeletal, conn tissue - Oth spec |
5/657 (0.76%)
|
5 |
7/654 (1.07%)
|
7 |
Myalgia |
2/657 (0.30%)
|
5 |
4/654 (0.61%)
|
4 |
Neck pain |
3/657 (0.46%)
|
3 |
0/654 (0.00%)
|
0 |
Osteoporosis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Pain in extremity |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
2 |
Neoplasms benign, malignant and unspecified (incl cysts and polyps) |
|
|
Myelodysplastic syndrome |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Neoplasms benign, mal, uncpec - Oth spec |
16/657 (2.44%)
|
19 |
27/654 (4.13%)
|
38 |
Tumor pain |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
2 |
Nervous system disorders |
|
|
Amnesia |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Aphonia |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Cognitive disturbance |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Dizziness |
6/657 (0.91%)
|
6 |
8/654 (1.22%)
|
10 |
Dysarthria |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
2 |
Dysgeusia |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Encephalopathy |
1/657 (0.15%)
|
1 |
3/654 (0.46%)
|
4 |
Extrapyramidal disorder |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Facial nerve disorder |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Headache |
3/657 (0.46%)
|
7 |
5/654 (0.76%)
|
6 |
Intracranial hemorrhage |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Memory impairment |
3/657 (0.46%)
|
3 |
3/654 (0.46%)
|
3 |
Nervous system disorders - Oth spec |
3/657 (0.46%)
|
3 |
4/654 (0.61%)
|
4 |
Peripheral sensory neuropathy |
4/657 (0.61%)
|
4 |
2/654 (0.31%)
|
2 |
Presyncope |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Radiculitis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Seizure |
1/657 (0.15%)
|
1 |
3/654 (0.46%)
|
3 |
Stroke |
9/657 (1.37%)
|
10 |
8/654 (1.22%)
|
9 |
Syncope |
7/657 (1.07%)
|
7 |
6/654 (0.92%)
|
6 |
Transient ischemic attacks |
1/657 (0.15%)
|
2 |
1/654 (0.15%)
|
1 |
Tremor |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
2 |
Psychiatric disorders |
|
|
Anxiety |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Confusion |
5/657 (0.76%)
|
5 |
8/654 (1.22%)
|
9 |
Delirium |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Depression |
1/657 (0.15%)
|
1 |
3/654 (0.46%)
|
3 |
Insomnia |
4/657 (0.61%)
|
7 |
1/654 (0.15%)
|
1 |
Psychosis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Suicidal ideation |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Renal and urinary disorders |
|
|
Acute kidney injury |
4/657 (0.61%)
|
4 |
10/654 (1.53%)
|
11 |
Bladder perforation |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Bladder spasm |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
4 |
Chronic kidney disease |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Cystitis noninfective |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Hematuria |
10/657 (1.52%)
|
10 |
10/654 (1.53%)
|
10 |
Renal and urinary disorders - Oth spec |
5/657 (0.76%)
|
5 |
4/654 (0.61%)
|
4 |
Renal calculi |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Urinary frequency |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Urinary incontinence |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Urinary retention |
1/657 (0.15%)
|
1 |
4/654 (0.61%)
|
5 |
Urinary tract obstruction |
5/657 (0.76%)
|
5 |
6/654 (0.92%)
|
6 |
Reproductive system and breast disorders |
|
|
Erectile dysfunction |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Genital edema |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Pelvic pain |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Respiratory, thoracic and mediastinal disorders |
|
|
Aspiration |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Atelectasis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Bronchial obstruction |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Bronchospasm |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Cough |
1/657 (0.15%)
|
4 |
3/654 (0.46%)
|
3 |
Dyspnea |
15/657 (2.28%)
|
19 |
15/654 (2.29%)
|
17 |
Hypoxia |
2/657 (0.30%)
|
2 |
1/654 (0.15%)
|
1 |
Laryngeal hemorrhage |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Pleural effusion |
2/657 (0.30%)
|
2 |
1/654 (0.15%)
|
1 |
Pleural hemorrhage |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Pneumonitis |
0/657 (0.00%)
|
0 |
3/654 (0.46%)
|
4 |
Pneumothorax |
2/657 (0.30%)
|
2 |
1/654 (0.15%)
|
1 |
Productive cough |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Pulmonary edema |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Pulmonary hypertension |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Resp, thoracic, mediastinal - Oth spec |
1/657 (0.15%)
|
1 |
4/654 (0.61%)
|
5 |
Respiratory failure |
2/657 (0.30%)
|
2 |
1/654 (0.15%)
|
1 |
Skin and subcutaneous tissue disorders |
|
|
Hyperhidrosis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Hypertrichosis |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Pain of skin |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Rash maculo-papular |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Skin and subcut tissue disord - Oth spec |
2/657 (0.30%)
|
3 |
1/654 (0.15%)
|
1 |
Social circumstances |
|
|
Social circumstances - Other, specify |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Surgical and medical procedures |
|
|
Surgical and medical proced - Oth spec |
7/657 (1.07%)
|
14 |
1/654 (0.15%)
|
1 |
Vascular disorders |
|
|
Hematoma |
1/657 (0.15%)
|
3 |
2/654 (0.31%)
|
2 |
Hot flashes |
11/657 (1.67%)
|
18 |
8/654 (1.22%)
|
10 |
Hypertension |
26/657 (3.96%)
|
39 |
31/654 (4.74%)
|
44 |
Hypotension |
3/657 (0.46%)
|
3 |
5/654 (0.76%)
|
5 |
Peripheral ischemia |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Thromboembolic event |
10/657 (1.52%)
|
13 |
3/654 (0.46%)
|
3 |
Vascular disorders - Other, specify |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Term from vocabulary, MedDRA 12
Indicates events were collected by systematic assessment
|
|
Frequency Threshold for Reporting Other Adverse Events
|
0%
|
|
Arm A: (Enzalutamide)
|
Arm B: (Enzalutamide, Abiraterone, Prednisone)
|
|
Affected / at Risk (%) |
# Events
|
Affected / at Risk (%) |
# Events
|
Total |
645/657 (98.17%)
|
|
627/654 (95.87%)
|
|
Blood and lymphatic system disorders |
|
|
Anemia |
188/657 (28.61%)
|
1185 |
170/654 (25.99%)
|
1064 |
Blood and lymph sys disorders - Oth Spec |
5/657 (0.76%)
|
10 |
9/654 (1.38%)
|
38 |
Febrile neutropenia |
1/657 (0.15%)
|
2 |
0/654 (0.00%)
|
0 |
Leukocytosis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Thrombotic thrombocytopenic purpura |
1/657 (0.15%)
|
2 |
1/654 (0.15%)
|
2 |
Cardiac disorders |
|
|
Aortic valve disease |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
7 |
Atrial fibrillation |
5/657 (0.76%)
|
33 |
7/654 (1.07%)
|
21 |
Atrial flutter |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Cardiac disorders - Other, specify |
3/657 (0.46%)
|
6 |
7/654 (1.07%)
|
20 |
Chest pain - cardiac |
4/657 (0.61%)
|
5 |
8/654 (1.22%)
|
9 |
Heart failure |
1/657 (0.15%)
|
1 |
3/654 (0.46%)
|
3 |
Myocardial infarction |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Palpitations |
6/657 (0.91%)
|
10 |
5/654 (0.76%)
|
14 |
Paroxysmal atrial tachycardia |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Pericardial effusion |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Restrictive cardiomyopathy |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Sinus bradycardia |
6/657 (0.91%)
|
21 |
9/654 (1.38%)
|
40 |
Sinus tachycardia |
4/657 (0.61%)
|
5 |
5/654 (0.76%)
|
15 |
Supraventricular tachycardia |
1/657 (0.15%)
|
2 |
0/654 (0.00%)
|
0 |
Ventricular tachycardia |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Congenital, familial and genetic disorders |
|
|
Congen, family, genetic disord -Oth spec |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Ear and labyrinth disorders |
|
|
Ear and labyrinth disorders - Oth spec |
1/657 (0.15%)
|
2 |
2/654 (0.31%)
|
2 |
Ear pain |
2/657 (0.30%)
|
2 |
2/654 (0.31%)
|
5 |
External ear pain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Hearing impaired |
6/657 (0.91%)
|
26 |
6/654 (0.92%)
|
23 |
Tinnitus |
9/657 (1.37%)
|
33 |
10/654 (1.53%)
|
32 |
Vertigo |
7/657 (1.07%)
|
43 |
7/654 (1.07%)
|
27 |
Vestibular disorder |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Endocrine disorders |
|
|
Endocrine disorders - Other, specify |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
6 |
Hyperthyroidism |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Hypothyroidism |
3/657 (0.46%)
|
20 |
0/654 (0.00%)
|
0 |
Eye disorders |
|
|
Blurred vision |
15/657 (2.28%)
|
76 |
18/654 (2.75%)
|
38 |
Cataract |
2/657 (0.30%)
|
2 |
4/654 (0.61%)
|
15 |
Dry eye |
3/657 (0.46%)
|
7 |
2/654 (0.31%)
|
15 |
Eye disorders - Other, specify |
10/657 (1.52%)
|
23 |
10/654 (1.53%)
|
40 |
Eye pain |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Floaters |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
3 |
Glaucoma |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Retinal detachment |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Vitreous hemorrhage |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
3 |
Watering eyes |
3/657 (0.46%)
|
19 |
2/654 (0.31%)
|
26 |
Gastrointestinal disorders |
|
|
Abdominal distension |
5/657 (0.76%)
|
13 |
1/654 (0.15%)
|
1 |
Abdominal pain |
28/657 (4.26%)
|
88 |
22/654 (3.36%)
|
76 |
Ascites |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Bloating |
8/657 (1.22%)
|
14 |
6/654 (0.92%)
|
31 |
Colitis |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Colonic fistula |
1/657 (0.15%)
|
10 |
0/654 (0.00%)
|
0 |
Colonic hemorrhage |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Constipation |
245/657 (37.29%)
|
1509 |
216/654 (33.03%)
|
1315 |
Dental caries |
1/657 (0.15%)
|
2 |
0/654 (0.00%)
|
0 |
Diarrhea |
201/657 (30.59%)
|
1016 |
172/654 (26.30%)
|
530 |
Dry mouth |
13/657 (1.98%)
|
91 |
11/654 (1.68%)
|
58 |
Dyspepsia |
129/657 (19.63%)
|
682 |
132/654 (20.18%)
|
678 |
Dysphagia |
9/657 (1.37%)
|
30 |
5/654 (0.76%)
|
6 |
Esophageal obstruction |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Esophageal pain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Esophageal ulcer |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Esophagitis |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Fecal incontinence |
1/657 (0.15%)
|
1 |
3/654 (0.46%)
|
4 |
Flatulence |
12/657 (1.83%)
|
129 |
2/654 (0.31%)
|
4 |
Gastritis |
2/657 (0.30%)
|
4 |
2/654 (0.31%)
|
2 |
Gastroesophageal reflux disease |
10/657 (1.52%)
|
44 |
12/654 (1.83%)
|
38 |
Gastrointestinal disorders - Oth spec |
12/657 (1.83%)
|
20 |
13/654 (1.99%)
|
47 |
Gastrointestinal pain |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Gingival pain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
5 |
Hemorrhoidal hemorrhage |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Hemorrhoids |
4/657 (0.61%)
|
32 |
2/654 (0.31%)
|
8 |
Ileus |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Mucositis oral |
3/657 (0.46%)
|
3 |
2/654 (0.31%)
|
5 |
Nausea |
96/657 (14.61%)
|
288 |
120/654 (18.35%)
|
384 |
Oral dysesthesia |
2/657 (0.30%)
|
4 |
0/654 (0.00%)
|
0 |
Oral hemorrhage |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Oral pain |
1/657 (0.15%)
|
2 |
2/654 (0.31%)
|
2 |
Rectal hemorrhage |
2/657 (0.30%)
|
10 |
2/654 (0.31%)
|
2 |
Rectal pain |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
3 |
Small intestinal obstruction |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Stomach pain |
6/657 (0.91%)
|
14 |
1/654 (0.15%)
|
3 |
Tooth development disorder |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Tooth discoloration |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
15 |
Toothache |
2/657 (0.30%)
|
5 |
0/654 (0.00%)
|
0 |
Vomiting |
87/657 (13.24%)
|
165 |
80/654 (12.23%)
|
133 |
General disorders |
|
|
Chills |
6/657 (0.91%)
|
6 |
7/654 (1.07%)
|
11 |
Edema face |
1/657 (0.15%)
|
1 |
5/654 (0.76%)
|
36 |
Edema limbs |
173/657 (26.33%)
|
1354 |
196/654 (29.97%)
|
1407 |
Facial pain |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
5 |
Fatigue |
556/657 (84.63%)
|
7352 |
526/654 (80.43%)
|
6588 |
Fever |
5/657 (0.76%)
|
7 |
6/654 (0.92%)
|
7 |
Flu like symptoms |
12/657 (1.83%)
|
15 |
8/654 (1.22%)
|
11 |
Gait disturbance |
9/657 (1.37%)
|
63 |
10/654 (1.53%)
|
32 |
Gen disord and admin site conds-Oth spec |
14/657 (2.13%)
|
26 |
16/654 (2.45%)
|
20 |
Injection site reaction |
1/657 (0.15%)
|
2 |
1/654 (0.15%)
|
1 |
Localized edema |
5/657 (0.76%)
|
23 |
6/654 (0.92%)
|
13 |
Malaise |
6/657 (0.91%)
|
26 |
3/654 (0.46%)
|
7 |
Neck edema |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Non-cardiac chest pain |
13/657 (1.98%)
|
23 |
5/654 (0.76%)
|
6 |
Pain |
44/657 (6.70%)
|
150 |
43/654 (6.57%)
|
199 |
Hepatobiliary disorders |
|
|
Bile duct stenosis |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Hepatic failure |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Hepatobiliary disorders - Other, specify |
1/657 (0.15%)
|
1 |
4/654 (0.61%)
|
4 |
Immune system disorders |
|
|
Allergic reaction |
2/657 (0.30%)
|
3 |
2/654 (0.31%)
|
4 |
Infections and infestations |
|
|
Anorectal infection |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Bladder infection |
1/657 (0.15%)
|
1 |
4/654 (0.61%)
|
9 |
Bronchial infection |
5/657 (0.76%)
|
5 |
1/654 (0.15%)
|
1 |
Conjunctivitis |
5/657 (0.76%)
|
13 |
1/654 (0.15%)
|
1 |
Eye infection |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Gum infection |
3/657 (0.46%)
|
3 |
0/654 (0.00%)
|
0 |
Infections and infestations - Oth spec |
11/657 (1.67%)
|
18 |
20/654 (3.06%)
|
23 |
Joint infection |
1/657 (0.15%)
|
2 |
0/654 (0.00%)
|
0 |
Kidney infection |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
2 |
Laryngitis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Lip infection |
2/657 (0.30%)
|
2 |
1/654 (0.15%)
|
2 |
Lung infection |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
2 |
Mucosal infection |
2/657 (0.30%)
|
2 |
4/654 (0.61%)
|
8 |
Nail infection |
2/657 (0.30%)
|
2 |
2/654 (0.31%)
|
2 |
Otitis media |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
3 |
Papulopustular rash |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
5 |
Pharyngitis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Scrotal infection |
1/657 (0.15%)
|
2 |
0/654 (0.00%)
|
0 |
Sepsis |
0/657 (0.00%)
|
0 |
3/654 (0.46%)
|
3 |
Sinusitis |
2/657 (0.30%)
|
2 |
4/654 (0.61%)
|
6 |
Skin infection |
7/657 (1.07%)
|
9 |
10/654 (1.53%)
|
14 |
Soft tissue infection |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Tooth infection |
3/657 (0.46%)
|
3 |
2/654 (0.31%)
|
2 |
Upper respiratory infection |
18/657 (2.74%)
|
23 |
13/654 (1.99%)
|
15 |
Urinary tract infection |
16/657 (2.44%)
|
20 |
22/654 (3.36%)
|
37 |
Wound infection |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Injury, poisoning and procedural complications |
|
|
Ankle fracture |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Aortic injury |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Bruising |
12/657 (1.83%)
|
38 |
30/654 (4.59%)
|
137 |
Fall |
31/657 (4.72%)
|
43 |
38/654 (5.81%)
|
66 |
Fracture |
6/657 (0.91%)
|
21 |
9/654 (1.38%)
|
37 |
Hip fracture |
2/657 (0.30%)
|
3 |
1/654 (0.15%)
|
1 |
Inj, pois and proced complic - Oth spec |
5/657 (0.76%)
|
10 |
3/654 (0.46%)
|
5 |
Intraoperative head and neck injury |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Spinal fracture |
1/657 (0.15%)
|
1 |
6/654 (0.92%)
|
18 |
Urostomy obstruction |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Wound complication |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Wrist fracture |
1/657 (0.15%)
|
4 |
1/654 (0.15%)
|
8 |
Investigations |
|
|
Alanine aminotransferase increased |
40/657 (6.09%)
|
99 |
215/654 (32.87%)
|
703 |
Alkaline phosphatase increased |
66/657 (10.05%)
|
210 |
88/654 (13.46%)
|
281 |
Aspartate aminotransferase increased |
73/657 (11.11%)
|
232 |
217/654 (33.18%)
|
729 |
Blood antidiuretic hormone abnormal |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Blood bilirubin increased |
44/657 (6.70%)
|
154 |
87/654 (13.30%)
|
328 |
CO diffusing capacity decreased |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Cardiac troponin I increased |
2/657 (0.30%)
|
2 |
1/654 (0.15%)
|
1 |
Cholesterol high |
7/657 (1.07%)
|
41 |
6/654 (0.92%)
|
55 |
Creatinine increased |
45/657 (6.85%)
|
190 |
35/654 (5.35%)
|
103 |
GGT increased |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Hemoglobin increased |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
INR increased |
2/657 (0.30%)
|
2 |
2/654 (0.31%)
|
3 |
Investigations - Other, specify |
11/657 (1.67%)
|
22 |
14/654 (2.14%)
|
44 |
Lipase increased |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Lymphocyte count decreased |
56/657 (8.52%)
|
259 |
67/654 (10.24%)
|
300 |
Lymphocyte count increased |
2/657 (0.30%)
|
3 |
2/654 (0.31%)
|
2 |
Neutrophil count decreased |
33/657 (5.02%)
|
173 |
14/654 (2.14%)
|
66 |
Platelet count decreased |
38/657 (5.78%)
|
175 |
41/654 (6.27%)
|
202 |
Weight gain |
15/657 (2.28%)
|
93 |
10/654 (1.53%)
|
62 |
Weight loss |
60/657 (9.13%)
|
222 |
72/654 (11.01%)
|
295 |
White blood cell decreased |
65/657 (9.89%)
|
451 |
36/654 (5.50%)
|
103 |
Metabolism and nutrition disorders |
|
|
Anorexia |
85/657 (12.94%)
|
458 |
86/654 (13.15%)
|
301 |
Dehydration |
8/657 (1.22%)
|
9 |
6/654 (0.92%)
|
9 |
Glucose intolerance |
0/657 (0.00%)
|
0 |
3/654 (0.46%)
|
59 |
Hypercalcemia |
18/657 (2.74%)
|
30 |
16/654 (2.45%)
|
29 |
Hyperglycemia |
338/657 (51.45%)
|
2782 |
321/654 (49.08%)
|
2468 |
Hyperkalemia |
32/657 (4.87%)
|
80 |
15/654 (2.29%)
|
68 |
Hypermagnesemia |
3/657 (0.46%)
|
3 |
2/654 (0.31%)
|
2 |
Hypernatremia |
18/657 (2.74%)
|
35 |
22/654 (3.36%)
|
30 |
Hypertriglyceridemia |
7/657 (1.07%)
|
32 |
6/654 (0.92%)
|
8 |
Hyperuricemia |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Hypoalbuminemia |
50/657 (7.61%)
|
165 |
58/654 (8.87%)
|
189 |
Hypocalcemia |
27/657 (4.11%)
|
53 |
23/654 (3.52%)
|
53 |
Hypoglycemia |
7/657 (1.07%)
|
10 |
3/654 (0.46%)
|
4 |
Hypokalemia |
86/657 (13.09%)
|
220 |
179/654 (27.37%)
|
469 |
Hypomagnesemia |
5/657 (0.76%)
|
6 |
2/654 (0.31%)
|
11 |
Hyponatremia |
52/657 (7.91%)
|
136 |
47/654 (7.19%)
|
112 |
Hypophosphatemia |
11/657 (1.67%)
|
18 |
13/654 (1.99%)
|
29 |
Metabolism, nutrition disord - Oth spec |
8/657 (1.22%)
|
10 |
7/654 (1.07%)
|
39 |
Obesity |
2/657 (0.30%)
|
2 |
0/654 (0.00%)
|
0 |
Musculoskeletal and connective tissue disorders |
|
|
Arthralgia |
291/657 (44.29%)
|
2233 |
227/654 (34.71%)
|
1798 |
Arthritis |
13/657 (1.98%)
|
30 |
14/654 (2.14%)
|
50 |
Back pain |
75/657 (11.42%)
|
260 |
65/654 (9.94%)
|
333 |
Bone pain |
300/657 (45.66%)
|
1751 |
261/654 (39.91%)
|
1524 |
Buttock pain |
1/657 (0.15%)
|
4 |
1/654 (0.15%)
|
22 |
Chest wall pain |
1/657 (0.15%)
|
1 |
4/654 (0.61%)
|
6 |
Flank pain |
5/657 (0.76%)
|
6 |
8/654 (1.22%)
|
14 |
Generalized muscle weakness |
42/657 (6.39%)
|
194 |
51/654 (7.80%)
|
231 |
Joint effusion |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Joint range of motion decreased |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Muscle weakness lower limb |
17/657 (2.59%)
|
110 |
30/654 (4.59%)
|
106 |
Muscle weakness upper limb |
0/657 (0.00%)
|
0 |
3/654 (0.46%)
|
16 |
Musculoskeletal, conn tissue - Oth spec |
21/657 (3.20%)
|
67 |
22/654 (3.36%)
|
110 |
Myalgia |
189/657 (28.77%)
|
1102 |
170/654 (25.99%)
|
915 |
Neck pain |
13/657 (1.98%)
|
51 |
7/654 (1.07%)
|
30 |
Osteonecrosis of jaw |
2/657 (0.30%)
|
16 |
2/654 (0.31%)
|
15 |
Osteoporosis |
2/657 (0.30%)
|
7 |
4/654 (0.61%)
|
21 |
Pain in extremity |
49/657 (7.46%)
|
167 |
44/654 (6.73%)
|
220 |
Neoplasms benign, malignant and unspecified (incl cysts and polyps) |
|
|
Neoplasms benign, mal, uncpec - Oth spec |
3/657 (0.46%)
|
5 |
2/654 (0.31%)
|
2 |
Tumor pain |
1/657 (0.15%)
|
2 |
0/654 (0.00%)
|
0 |
Nervous system disorders |
|
|
Akathisia |
3/657 (0.46%)
|
21 |
2/654 (0.31%)
|
2 |
Amnesia |
1/657 (0.15%)
|
1 |
3/654 (0.46%)
|
3 |
Ataxia |
3/657 (0.46%)
|
6 |
4/654 (0.61%)
|
14 |
Brachial plexopathy |
1/657 (0.15%)
|
2 |
0/654 (0.00%)
|
0 |
Cognitive disturbance |
11/657 (1.67%)
|
81 |
12/654 (1.83%)
|
113 |
Concentration impairment |
5/657 (0.76%)
|
26 |
7/654 (1.07%)
|
55 |
Dizziness |
64/657 (9.74%)
|
237 |
82/654 (12.54%)
|
298 |
Dysarthria |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Dysesthesia |
3/657 (0.46%)
|
26 |
0/654 (0.00%)
|
0 |
Dysgeusia |
42/657 (6.39%)
|
258 |
38/654 (5.81%)
|
161 |
Dysphasia |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Extrapyramidal disorder |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
8 |
Facial muscle weakness |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Facial nerve disorder |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Headache |
163/657 (24.81%)
|
1000 |
176/654 (26.91%)
|
826 |
Lethargy |
2/657 (0.30%)
|
3 |
3/654 (0.46%)
|
9 |
Memory impairment |
37/657 (5.63%)
|
255 |
39/654 (5.96%)
|
351 |
Movements involuntary |
1/657 (0.15%)
|
3 |
2/654 (0.31%)
|
9 |
Muscle weakness left-sided |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
4 |
Muscle weakness right-sided |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Nervous system disorders - Oth spec |
13/657 (1.98%)
|
104 |
16/654 (2.45%)
|
88 |
Neuralgia |
1/657 (0.15%)
|
2 |
2/654 (0.31%)
|
5 |
Paresthesia |
12/657 (1.83%)
|
44 |
11/654 (1.68%)
|
44 |
Peripheral motor neuropathy |
7/657 (1.07%)
|
36 |
8/654 (1.22%)
|
9 |
Peripheral sensory neuropathy |
43/657 (6.54%)
|
287 |
31/654 (4.74%)
|
123 |
Presyncope |
2/657 (0.30%)
|
2 |
4/654 (0.61%)
|
4 |
Seizure |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Somnolence |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Spasticity |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Stroke |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Syncope |
8/657 (1.22%)
|
8 |
5/654 (0.76%)
|
10 |
Transient ischemic attacks |
2/657 (0.30%)
|
2 |
1/654 (0.15%)
|
1 |
Tremor |
8/657 (1.22%)
|
33 |
13/654 (1.99%)
|
60 |
Vasovagal reaction |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Psychiatric disorders |
|
|
Agitation |
1/657 (0.15%)
|
2 |
5/654 (0.76%)
|
11 |
Anxiety |
27/657 (4.11%)
|
67 |
32/654 (4.89%)
|
182 |
Confusion |
15/657 (2.28%)
|
18 |
18/654 (2.75%)
|
51 |
Delirium |
1/657 (0.15%)
|
3 |
0/654 (0.00%)
|
0 |
Depression |
36/657 (5.48%)
|
155 |
44/654 (6.73%)
|
218 |
Hallucinations |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
25 |
Insomnia |
210/657 (31.96%)
|
1574 |
203/654 (31.04%)
|
1503 |
Irritability |
4/657 (0.61%)
|
8 |
1/654 (0.15%)
|
1 |
Libido decreased |
2/657 (0.30%)
|
10 |
1/654 (0.15%)
|
3 |
Personality change |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Psychiatric disorders - Other, specify |
3/657 (0.46%)
|
9 |
5/654 (0.76%)
|
9 |
Restlessness |
1/657 (0.15%)
|
10 |
3/654 (0.46%)
|
33 |
Renal and urinary disorders |
|
|
Bladder spasm |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Chronic kidney disease |
7/657 (1.07%)
|
45 |
5/654 (0.76%)
|
30 |
Cystitis noninfective |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Hematuria |
31/657 (4.72%)
|
69 |
31/654 (4.74%)
|
64 |
Proteinuria |
0/657 (0.00%)
|
0 |
3/654 (0.46%)
|
14 |
Renal and urinary disorders - Oth spec |
21/657 (3.20%)
|
66 |
17/654 (2.60%)
|
51 |
Renal calculi |
1/657 (0.15%)
|
1 |
3/654 (0.46%)
|
9 |
Renal colic |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Urinary frequency |
47/657 (7.15%)
|
243 |
44/654 (6.73%)
|
266 |
Urinary incontinence |
26/657 (3.96%)
|
141 |
23/654 (3.52%)
|
136 |
Urinary retention |
7/657 (1.07%)
|
16 |
13/654 (1.99%)
|
28 |
Urinary tract obstruction |
3/657 (0.46%)
|
9 |
2/654 (0.31%)
|
2 |
Urinary tract pain |
5/657 (0.76%)
|
12 |
2/654 (0.31%)
|
2 |
Urinary urgency |
12/657 (1.83%)
|
60 |
8/654 (1.22%)
|
27 |
Urine discoloration |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
5 |
Reproductive system and breast disorders |
|
|
Breast pain |
6/657 (0.91%)
|
28 |
1/654 (0.15%)
|
1 |
Erectile dysfunction |
21/657 (3.20%)
|
318 |
13/654 (1.99%)
|
184 |
Genital edema |
1/657 (0.15%)
|
3 |
0/654 (0.00%)
|
0 |
Gynecomastia |
24/657 (3.65%)
|
243 |
5/654 (0.76%)
|
57 |
Pelvic pain |
6/657 (0.91%)
|
9 |
6/654 (0.92%)
|
33 |
Penile pain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
4 |
Perineal pain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Reproductive system and breast -Oth spec |
2/657 (0.30%)
|
3 |
1/654 (0.15%)
|
1 |
Scrotal pain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
2 |
Testicular disorder |
1/657 (0.15%)
|
2 |
1/654 (0.15%)
|
3 |
Testicular pain |
4/657 (0.61%)
|
13 |
6/654 (0.92%)
|
61 |
Respiratory, thoracic and mediastinal disorders |
|
|
Adult respiratory distress syndrome |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Allergic rhinitis |
8/657 (1.22%)
|
77 |
16/654 (2.45%)
|
108 |
Atelectasis |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Cough |
191/657 (29.07%)
|
899 |
206/654 (31.50%)
|
924 |
Dyspnea |
189/657 (28.77%)
|
1380 |
201/654 (30.73%)
|
1391 |
Epistaxis |
7/657 (1.07%)
|
12 |
5/654 (0.76%)
|
8 |
Hiccups |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Hoarseness |
8/657 (1.22%)
|
33 |
2/654 (0.31%)
|
3 |
Hypoxia |
0/657 (0.00%)
|
0 |
3/654 (0.46%)
|
3 |
Laryngeal edema |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Laryngeal hemorrhage |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Laryngeal inflammation |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Nasal congestion |
14/657 (2.13%)
|
24 |
9/654 (1.38%)
|
48 |
Pleural effusion |
3/657 (0.46%)
|
3 |
2/654 (0.31%)
|
2 |
Pleuritic pain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Pneumonitis |
2/657 (0.30%)
|
2 |
2/654 (0.31%)
|
2 |
Pneumothorax |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
4 |
Postnasal drip |
4/657 (0.61%)
|
5 |
2/654 (0.31%)
|
4 |
Productive cough |
1/657 (0.15%)
|
1 |
3/654 (0.46%)
|
4 |
Pulmonary edema |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Pulmonary hypertension |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Resp, thoracic, mediastinal - Oth spec |
3/657 (0.46%)
|
17 |
6/654 (0.92%)
|
7 |
Respiratory failure |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
2 |
Sinus disorder |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
2 |
Sinus pain |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Sleep apnea |
4/657 (0.61%)
|
18 |
4/654 (0.61%)
|
4 |
Sneezing |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Sore throat |
12/657 (1.83%)
|
17 |
2/654 (0.31%)
|
3 |
Voice alteration |
1/657 (0.15%)
|
1 |
2/654 (0.31%)
|
4 |
Wheezing |
4/657 (0.61%)
|
6 |
3/654 (0.46%)
|
3 |
Skin and subcutaneous tissue disorders |
|
|
Alopecia |
3/657 (0.46%)
|
9 |
12/654 (1.83%)
|
119 |
Dry skin |
25/657 (3.81%)
|
146 |
16/654 (2.45%)
|
107 |
Erythema multiforme |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
3 |
Hyperhidrosis |
8/657 (1.22%)
|
52 |
6/654 (0.92%)
|
21 |
Hypertrichosis |
2/657 (0.30%)
|
29 |
0/654 (0.00%)
|
0 |
Nail discoloration |
2/657 (0.30%)
|
3 |
1/654 (0.15%)
|
1 |
Nail ridging |
3/657 (0.46%)
|
14 |
2/654 (0.31%)
|
8 |
Pain of skin |
1/657 (0.15%)
|
1 |
1/654 (0.15%)
|
1 |
Pruritus |
10/657 (1.52%)
|
46 |
14/654 (2.14%)
|
35 |
Purpura |
0/657 (0.00%)
|
0 |
2/654 (0.31%)
|
4 |
Rash acneiform |
3/657 (0.46%)
|
11 |
3/654 (0.46%)
|
4 |
Rash maculo-papular |
18/657 (2.74%)
|
62 |
22/654 (3.36%)
|
44 |
Skin and subcut tissue disord - Oth spec |
24/657 (3.65%)
|
98 |
26/654 (3.98%)
|
80 |
Skin hyperpigmentation |
1/657 (0.15%)
|
7 |
2/654 (0.31%)
|
8 |
Social circumstances |
|
|
Social circumstances - Other, specify |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Surgical and medical procedures |
|
|
Surgical and medical proced - Oth spec |
3/657 (0.46%)
|
4 |
3/654 (0.46%)
|
4 |
Vascular disorders |
|
|
Flushing |
4/657 (0.61%)
|
34 |
10/654 (1.53%)
|
56 |
Hematoma |
5/657 (0.76%)
|
5 |
1/654 (0.15%)
|
1 |
Hot flashes |
416/657 (63.32%)
|
5649 |
438/654 (66.97%)
|
5781 |
Hypertension |
413/657 (62.86%)
|
5471 |
416/654 (63.61%)
|
5628 |
Hypotension |
11/657 (1.67%)
|
16 |
10/654 (1.53%)
|
11 |
Lymph leakage |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Lymphedema |
0/657 (0.00%)
|
0 |
1/654 (0.15%)
|
1 |
Peripheral ischemia |
1/657 (0.15%)
|
1 |
0/654 (0.00%)
|
0 |
Thromboembolic event |
2/657 (0.30%)
|
2 |
4/654 (0.61%)
|
5 |
Vascular disorders - Other, specify |
5/657 (0.76%)
|
15 |
2/654 (0.31%)
|
31 |
Vasculitis |
1/657 (0.15%)
|
15 |
0/654 (0.00%)
|
0 |
Term from vocabulary, MedDRA 12
Indicates events were collected by systematic assessment
|